Comparison of analgesic effect of dexmedetomidine with 0.1% ropivacaine and 0.25 mug /ml sufentanil in epidural delivery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049240

Enrollment

Unknown

Registered

2021-07-28

Start date

2021-07-17

Completion date

Unknown

Last updated

2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group FD0:Ropivacaine plus sufentanil

Group FD0.05:Ropivacaine+sufentanil+0.05µg/kg dexmedetomidine

Group FD0.1:Ropivacaine+sufentanil+0.1µg/kg dexmedetomidine

Group FD0.2:Ropivacaine+sufentanil+0.2µg/kg dexmedetomidine

Eligibility

Sex/Gender

Female

Age

23 Years to 45 Years

Inclusion criteria

Inclusion criteria: Full-term expectant mothers who voluntarily requested epidural labor analgesia and met the case selection criteria.

Exclusion criteria

Exclusion criteria: 1. Local anesthetic allergy, neurological or neuromuscular disease, psychological disorder, contraindications to spinal anesthesia; 2. History of recent use of analgesics; 3. High-risk pregnancy (gestational diabetes, hypertension, placenta previa, placental abruption, preeclampsia), fetal distress, oligohydramnios, contamination of amniotic fluid, relative cephalopelvic disproportion, intrauterine infection and other complications, inability to tolerate labor.

Design outcomes

Primary

Measure	Time frame
Visual Analog Pain Rating Scale;	—

Countries

China

Contacts

Public ContactGuo Yaqiu

Ji'nan Maternity and Child Care Hospital

guoyaqiu0055@163.com+86 18053158617

Outcome results